Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 26503 [2018-12269]

Download as PDF 26503 Federal Register / Vol. 83, No. 110 / Thursday, June 7, 2018 / Notices Date Document December 17, 2012 ........ December 17, 2015 ........ February 1, 2009 ............ May 15, 2017 .................. April 25, 2016 ................. April 25, 2016 ................. Submission of PGEC DFP ..................................................................................................... Submission of PGEC Triennial DFP ...................................................................................... Environmental Assessment for Final Rule—Decommissioning Planning ............................. Note to File Re: Section 7 Consultations for ISFSI DFPs ..................................................... Consultation Letter (ML16120A553–RLSO) .......................................................................... Letter to M. Fris, U.S. Fish and Wildlife Service Re: NRC Preliminary Determination of No Effects Regarding the Diablo Canyon ISFSI DFP. Final EA for the Approval of the DFP .................................................................................... May 11, 2018 .................. Dated at Rockville, Maryland, this 4th day of June, 2018. For the Nuclear Regulatory Commission. John McKirgan, Branch Chief, Spent Fuel Licensing Branch, Division of Spent Fuel Management, Office of Nuclear Material Safety and Safeguards. [FR Doc. 2018–12249 Filed 6–6–18; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on July 16, 2018, to discuss the draft report of the ACMUI Subcommittee on Training and Experience Requirements for All Modalities. This report will include the subcommittee’s comments on the NRC staff’s evaluation of the training and experience requirements for different categories of radiopharmaceuticals in Title 10 of the Code of Federal Regulations, part 35, ‘‘Medical Use of Byproduct Material,’’ Subpart E, ‘‘Unsealed Byproduct Material—Written Directive Required.’’ Meeting information, including a copy of the agenda and handouts, will be available at http://www.nrc.gov/reading-rm/doccollections/acmui/meetings/2018.html. The agenda and handouts may also be obtained by contacting Ms. Maryann Ayoade using the information below. DATES: The teleconference meeting will be held on Monday, July 16, 2018, 2:00 p.m. to 4:00 p.m. Eastern Time. Public Participation: Any member of the public who wishes to participate in the teleconference should contact Ms. Ayoade using the contact information below or may register for the GoToWebinar at https:// attendee.gotowebinar.com/register/ 2201638285137455618. sradovich on DSK3GMQ082PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:19 Jun 06, 2018 Jkt 244001 ADAMS Accession No. Contact Information: Maryann Ayoade, email: Maryann.Ayoade@ nrc.gov, telephone: (301) 415–0862. Conduct of the Meeting Dr. Christopher Palestro, ACMUI Chairman, will preside over the meeting. Dr. Palestro will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Ayoade at the contact information listed above. All submittals must be received by July 11, 2018, three business days prior to the meeting, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meetings, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on the ACMUI’s website http://www.nrc.gov/ reading-rm/doc-collections/acmui/ meetings/2018.html on or about August 27, 2018. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10 of the Code of Federal Regulations, part 7, ‘‘Advisory Committees.’’ Dated at Rockville, Maryland, this 4th day of June, 2018. For the Nuclear Regulatory Commission. Russell E. Chazell, Federal Advisory Committee Management Officer. [FR Doc. 2018–12269 Filed 6–6–18; 8:45 am] BILLING CODE 7590–01–P PO 00000 Frm 00094 Fmt 4703 Sfmt 4703 ML12353A315 ML15351A502 ML090500648 ML17135A062 ML17107A273 ML16120A606 ML18131A047 NUCLEAR REGULATORY COMMISSION [NRC–2018–0109] Draft Letter to the Nuclear Energy Institute Regarding the Clarification of Regulatory Paths for Lead Test Assemblies Nuclear Regulatory Commission. ACTION: Notice of availability; opportunity for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) is soliciting public comments on a draft letter to the Nuclear Energy Institute (NEI) clarifying the regulatory paths for the use of lead test assemblies (LTAs). This draft letter would finalize the NRC staff’s views on the preliminary positions regarding LTAs provided in a letter to NEI dated June 29, 2017. The NRC does not currently have consolidated regulatory guidance regarding the use of LTAs. Therefore, the NRC has drafted this letter to clarify its positions regarding the use of LTAs. These positions would affect light-water reactor licensees who wish to irradiate LTAs. DATES: Submit comments by June 27, 2018. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received before this date. ADDRESSES: You may submit comments by any of the following methods: • Federal Rulemaking website: Go to http://www.regulations.gov and search for Docket ID NRC–2018–0109. Address questions about NRC dockets to Jennifer Borges; telephone: 301–287–9127; email: Jennifer.Borges@nrc.gov. For technical questions, contact the individuals listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: May Ma, Office of Administration, Mail Stop: TWFN–7– A60M, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and SUMMARY: E:\FR\FM\07JNN1.SGM 07JNN1

Agencies

[Federal Register Volume 83, Number 110 (Thursday, June 7, 2018)]
[Notices]
[Page 26503]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-12269]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on July 16, 2018, to discuss the draft report of the 
ACMUI Subcommittee on Training and Experience Requirements for All 
Modalities. This report will include the subcommittee's comments on the 
NRC staff's evaluation of the training and experience requirements for 
different categories of radiopharmaceuticals in Title 10 of the Code of 
Federal Regulations, part 35, ``Medical Use of Byproduct Material,'' 
Subpart E, ``Unsealed Byproduct Material--Written Directive Required.'' 
Meeting information, including a copy of the agenda and handouts, will 
be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html. The agenda and handouts may also be obtained by 
contacting Ms. Maryann Ayoade using the information below.

DATES: The teleconference meeting will be held on Monday, July 16, 
2018, 2:00 p.m. to 4:00 p.m. Eastern Time.
    Public Participation: Any member of the public who wishes to 
participate in the teleconference should contact Ms. Ayoade using the 
contact information below or may register for the GoToWebinar at 
https://attendee.gotowebinar.com/register/2201638285137455618.
    Contact Information: Maryann Ayoade, email: [email protected], 
telephone: (301) 415-0862.

Conduct of the Meeting

    Dr. Christopher Palestro, ACMUI Chairman, will preside over the 
meeting. Dr. Palestro will conduct the meeting in a manner that will 
facilitate the orderly conduct of business. The following procedures 
apply to public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Ayoade at the contact information listed above. 
All submittals must be received by July 11, 2018, three business days 
prior to the meeting, and must pertain to the topic on the agenda for 
the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meetings, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
the ACMUI's website http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2018.html on or about August 27, 2018.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10 of the Code of Federal Regulations, part 7, ``Advisory Committees.''

    Dated at Rockville, Maryland, this 4th day of June, 2018.

    For the Nuclear Regulatory Commission.
Russell E. Chazell,
Federal Advisory Committee Management Officer.
[FR Doc. 2018-12269 Filed 6-6-18; 8:45 am]
 BILLING CODE 7590-01-P